Microbiology of the pars interarticularis in patients undergoing lumbar fusion surgery for chronic back pain and isthmic spondylolisthesis.
The Princess Alexandra Hospital Orthopaedic Department - Dr Kathleen Capehart & Dr Dihan Aponso (Principal Investigators)
50 participants
May 11, 2017
Observational
Conditions
Summary
This study aims to investigate whether an underlying subacute infection at the pars defect is a possible cause of pain in patients requiring lumbar spinal fusion surgery. The study will perform microbiological analysis of the bone, ligamentous, muscle and disc tissue at/adjacent to the pars defect, taken from normally discarded material intraoperatively. The presence of infection will be determined by positive bacterial culture from these sites and results analysed for statistical significance. Detection of bacteria would support an infectious rationale, as a source of back pain, in this population. This research endeavors to clarify the source of back pain in isthmic spondylolithesis patients the search for suitable, reliable and reproducible conservative treatments.
Eligibility
Inclusion Criteria4
- Patient age > 18 years
- Radiologically confirmed isthmic spondylolisthesis
- Planed for lumbar spinal fusion surgery
- Patients of specific staff specialists, seen at the Princess Alexandra Hospital Orthopaedic Outpatient Department Spine Clinics.
Exclusion Criteria2
- Age < 18 years
- Previous lumbar spinal surgery
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Prospective investigation of patients from the Princess Alexandra Hospital Orthopaedic outpatients, undergoing conventional surgical management (lumbar fusion surgery) for chronic low back pain associated with isthmic spondylolithesis and corresponding pars defect. Samples of bilateral pars defects, ligamentum flavum, intervertebral disc, and para-spinal muscle tissue will be collected; tissue normally discarded during your lumbar fusion surgery. These samples will then be sent for microbiological analysis. Approximately 50 patients will be recruited over 2 years.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12617000197336